MarketResearchReports.Biz has announced addition of new report “Global Epilepsy Drugs Market 2016-2020” to its database.
About the Epilepsy Drugs Market
Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.
Etiology
Etiology varies according to the age of a person. Some individuals genetically inherit the disease while the cause of the disease in others is unknown. Head injuries, tumors, autism spectrum disorder, or stroke can also cause the disorder.
Technavios analysts forecast the global epilepsy drugs market to grow at a CAGR of 4.45% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global epilepsy drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent epilepsy and related seizures. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio’s report, Global Epilepsy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/751774
Key vendors
Eisai
GSK
Pfizer
UCB
Other prominent vendors
AbbVie
Acorda Therapeutics
Alexza Pharmaceuticals
Aprecia Pharmaceuticals
Aurobindo Pharma
Biscayne Pharmaceuticals
CURx Pharmaceuticals
Dainippon Sumitomo Pharma
D-Pharm
- Hoffmann-La Roche
Grupo Ferrer Internacional
GW Pharmaceuticals
Insero Health
INSYS Therapeutics
Janssen Pharmaceuticals
Ligand Pharmaceuticals
- Lundbeck
MarcoPolo Pharmaceuticals
Marinus Pharmaceuticals
Meda
Neurelis
Nobelpharma
Novartis
Orphelia Pharma
SAGE Therapeutics
SciFlour
Sedor Pharmaceuticals
Shire
SK Biopharmaceuticals
Sun Pharmaceutical
Sunovion Pharmaceuticals (US)
Supernus Pharmaceuticals
Takeda
Turing Pharmaceuticals
Upsher-Smith
Valeant Pharmaceutical
Zogenix
Market driver
Tentative approval of late-stage pipeline molecules
For a full, detailed list, view our report
Market challenge
Social stigma associated with epilepsy
For a full, detailed list, view our report
Market trend
Reformulation of marketed drugs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
About Us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Browse Latest Industry Press Release http://www.marketresearchreports.biz/pressreleases
Contact Us
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz